TWST · NASDAQ · Biotechnology

Twist Bioscience (TWST)

Writes synthetic DNA on silicon for sequencing workflows, biological research, and antibody discovery.

$159.00
vs last close−5.60 (−3.40%)

In millions of USD, except per-share figures

In millionsQ4 FY23Sep 2023Q1 FY24Dec 2023Q2 FY24Mar 2024Q3 FY24Jun 2024Q4 FY24Sep 2024Q1 FY25Dec 2024Q2 FY25Mar 2025Q3 FY25Jun 2025Q4 FY25Sep 2025Q1 FY26Dec 2025Q2 FY26Mar 2026Q3 FY26Jun 2026
Revenue677175818589939699104111118
Cost of revenue424344464646474548505456
Gross profit252931353843465151545762
7576801247477888181879699
Research & development242324222121241817172018
475356575356646364707681
Selling & marketing000000007000
General & administrative0000000057000
Other expenses3004500000000
Operating income−50−47−49−89−36−35−42−30−30−33−39−36
44441325133−52
Interest income444443333222
Interest expense000000000000
Other non-operating income−4−4−4−4−1−3−3−51−300−2
Income before tax−46−43−45−85−35−31−3921−27−30−44−35
Income tax expense000000000000
Net income from continuing operations−46−43−45−86−34−32−3920−27−31−44−34
Other adjustments00000000000−1
Net income−46−43−45−86−35−32−3920−27−31−44−35
EPS, basic−$0.81−$0.75−$0.79−$1.47−$0.60−$0.53−$0.66$0.34−$0.45−$0.50−$0.71−$0.56
EPS, diluted−$0.81−$0.75−$0.79−$1.47−$0.60−$0.53−$0.66$0.33−$0.45−$0.50−$0.71−$0.56
Weighted average shares, basic575758585859606060616262
Weighted average shares, diluted575758585859606160616262
EBITDA−38−35−37−77−28−25−3326−21−27−32−28
Depreciation & amortization988876666667
EBIT−46−43−45−85−35−31−3921−27−33−39−35